eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics

Mattia Bosio, Oliver Drechsel, Rubayte Rahman, Francesc Muyas, Raquel Rabionet, Daniela Bezdan, Laura Domenech Salgado, Hyun Hor, Jean Jacques Schott, Francina Munell, Roger Colobran, Alfons Macaya, Xavier P. Estivill, Stephan Ossowski

Research output: Contribution to journalArticle

Abstract

Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20–30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here, we present the exome Disease Variant Analysis (eDiVA; http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing single-nucleotide variants and small insertions and deletions) for rare diseases using WES of families or parent–child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning-based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates that eDiVA consistently performed as a good or better than existing approach in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability.

Original languageEnglish
Pages (from-to)865-878
Number of pages14
JournalHuman mutation
Volume40
Issue number7
DOIs
Publication statusPublished - 1 Jul 2019

Fingerprint

Exome
Rare Diseases
Virulence
Phenotype
Benchmarking
Inborn Genetic Diseases
Nucleotides
Genotype
Mutation
Genes

Keywords

  • disease variant prioritization
  • machine learning
  • NGS diagnostics
  • rare genetic disease
  • whole-exome sequencing

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Bosio, M., Drechsel, O., Rahman, R., Muyas, F., Rabionet, R., Bezdan, D., ... Ossowski, S. (2019). eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics. Human mutation, 40(7), 865-878. https://doi.org/10.1002/humu.23772

eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics. / Bosio, Mattia; Drechsel, Oliver; Rahman, Rubayte; Muyas, Francesc; Rabionet, Raquel; Bezdan, Daniela; Domenech Salgado, Laura; Hor, Hyun; Schott, Jean Jacques; Munell, Francina; Colobran, Roger; Macaya, Alfons; Estivill, Xavier P.; Ossowski, Stephan.

In: Human mutation, Vol. 40, No. 7, 01.07.2019, p. 865-878.

Research output: Contribution to journalArticle

Bosio, M, Drechsel, O, Rahman, R, Muyas, F, Rabionet, R, Bezdan, D, Domenech Salgado, L, Hor, H, Schott, JJ, Munell, F, Colobran, R, Macaya, A, Estivill, XP & Ossowski, S 2019, 'eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics', Human mutation, vol. 40, no. 7, pp. 865-878. https://doi.org/10.1002/humu.23772
Bosio M, Drechsel O, Rahman R, Muyas F, Rabionet R, Bezdan D et al. eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics. Human mutation. 2019 Jul 1;40(7):865-878. https://doi.org/10.1002/humu.23772
Bosio, Mattia ; Drechsel, Oliver ; Rahman, Rubayte ; Muyas, Francesc ; Rabionet, Raquel ; Bezdan, Daniela ; Domenech Salgado, Laura ; Hor, Hyun ; Schott, Jean Jacques ; Munell, Francina ; Colobran, Roger ; Macaya, Alfons ; Estivill, Xavier P. ; Ossowski, Stephan. / eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics. In: Human mutation. 2019 ; Vol. 40, No. 7. pp. 865-878.
@article{b03790b28eae4dfaa9dcc0422fc0e05d,
title = "eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics",
abstract = "Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20–30{\%} reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here, we present the exome Disease Variant Analysis (eDiVA; http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing single-nucleotide variants and small insertions and deletions) for rare diseases using WES of families or parent–child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning-based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates that eDiVA consistently performed as a good or better than existing approach in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability.",
keywords = "disease variant prioritization, machine learning, NGS diagnostics, rare genetic disease, whole-exome sequencing",
author = "Mattia Bosio and Oliver Drechsel and Rubayte Rahman and Francesc Muyas and Raquel Rabionet and Daniela Bezdan and {Domenech Salgado}, Laura and Hyun Hor and Schott, {Jean Jacques} and Francina Munell and Roger Colobran and Alfons Macaya and Estivill, {Xavier P.} and Stephan Ossowski",
year = "2019",
month = "7",
day = "1",
doi = "10.1002/humu.23772",
language = "English",
volume = "40",
pages = "865--878",
journal = "Human Mutation",
issn = "1059-7794",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - eDiVA—Classification and prioritization of pathogenic variants for clinical diagnostics

AU - Bosio, Mattia

AU - Drechsel, Oliver

AU - Rahman, Rubayte

AU - Muyas, Francesc

AU - Rabionet, Raquel

AU - Bezdan, Daniela

AU - Domenech Salgado, Laura

AU - Hor, Hyun

AU - Schott, Jean Jacques

AU - Munell, Francina

AU - Colobran, Roger

AU - Macaya, Alfons

AU - Estivill, Xavier P.

AU - Ossowski, Stephan

PY - 2019/7/1

Y1 - 2019/7/1

N2 - Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20–30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here, we present the exome Disease Variant Analysis (eDiVA; http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing single-nucleotide variants and small insertions and deletions) for rare diseases using WES of families or parent–child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning-based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates that eDiVA consistently performed as a good or better than existing approach in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability.

AB - Mendelian diseases have shown to be an and efficient model for connecting genotypes to phenotypes and for elucidating the function of genes. Whole-exome sequencing (WES) accelerated the study of rare Mendelian diseases in families, allowing for directly pinpointing rare causal mutations in genic regions without the need for linkage analysis. However, the low diagnostic rates of 20–30% reported for multiple WES disease studies point to the need for improved variant pathogenicity classification and causal variant prioritization methods. Here, we present the exome Disease Variant Analysis (eDiVA; http://ediva.crg.eu), an automated computational framework for identification of causal genetic variants (coding/splicing single-nucleotide variants and small insertions and deletions) for rare diseases using WES of families or parent–child trios. eDiVA combines next-generation sequencing data analysis, comprehensive functional annotation, and causal variant prioritization optimized for familial genetic disease studies. eDiVA features a machine learning-based variant pathogenicity predictor combining various genomic and evolutionary signatures. Clinical information, such as disease phenotype or mode of inheritance, is incorporated to improve the precision of the prioritization algorithm. Benchmarking against state-of-the-art competitors demonstrates that eDiVA consistently performed as a good or better than existing approach in terms of detection rate and precision. Moreover, we applied eDiVA to several familial disease cases to demonstrate its clinical applicability.

KW - disease variant prioritization

KW - machine learning

KW - NGS diagnostics

KW - rare genetic disease

KW - whole-exome sequencing

UR - http://www.scopus.com/inward/record.url?scp=85069644655&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85069644655&partnerID=8YFLogxK

U2 - 10.1002/humu.23772

DO - 10.1002/humu.23772

M3 - Article

VL - 40

SP - 865

EP - 878

JO - Human Mutation

JF - Human Mutation

SN - 1059-7794

IS - 7

ER -